Daparange M 10/500 Tablet ER
Marketer
Neomac Pharmaceuticals Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Daparange M 10/500 Tablet ER
Daparange M 10/500 Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action formulation effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and promoting cardiovascular health. Daparange M 10/500 ER can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician, and discontinuation should only occur under their supervision; abrupt cessation may elevate blood sugar, potentially leading to serious consequences such as kidney failure and vision impairment. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration, which can be reduced by increased fluid intake. Genital fungal infections may occur; good hygiene practices are recommended to minimize this risk. Prior to initiating treatment, disclose any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption during treatment to reduce potential side effects. Regular blood glucose monitoring is essential while taking this medication.
Primary Ingredients of Daparange M 10/500 Tablet ER
No information provided. Please provide the text you wish to be rewritten.
Uses of Daparange M 10/500 Tablet ER
Managing type 2 diabetes
Major Benefits of Daparange M 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Daparange M 10/500 Tablet ER. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this extended-release medication with a meal.
Common Side effects of Daparange M 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Daparange M 10/500 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Daparange M 10/500 Extended-Release tablets should be administered with food.
How Daparange M 10/500 Tablet ER works:
Dapagliflozin and Metformin, combined as Daparange M 10/500 ER tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose output, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action synergistically regulates blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Daparange M 10/500 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Daparange M 10/500 tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Daparange M 10/500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Daparange M 10/500 Extended-Release tablets cautiously. Dosage modification of Daparange M 10/500 Extended-Release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Daparange M 10/500 Tablet ER. Dosage modifications for Daparange M 10/500 Tablet ER may be necessary; physician consultation is advised.
What if you forget to take Daparange M 10/500 Tablet ER :
Should you forget a Daparange M 10/500 Tablet ER dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Daparange M 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |



